Project name: Project category: Kind of research: Country: Principle investigator:

Inhalable formulation for regulating cytokine secretion of alveolar macrophages modifying x-box-binding protein 1 expression as potential approach in CF treatment

New Therapies
Immunology-Inflammation
Basic research Germany Prof. Dr. Mark Schneider
Start date: 01/03/2017
End date: 31/01/2018
Status: Finished
Abstract:

Please contact Dr. Sylvia Hafkemeyer (SHafkemeyer@muko.info) of the German CF patient organisation.

Institute: Saarland University
Department: Pharmacy, Biopharmaceutics & Pharmaceutical Technology
City: Saarbrücken
Project amount (€): 20.000

Contact information

Subscribe to newsletter